CYCLAFEM 0.5 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cyclafem 0.5, and what generic alternatives are available?
Cyclafem 0.5 is a drug marketed by Endo Operations and is included in one NDA.
The generic ingredient in CYCLAFEM 0.5 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CYCLAFEM 0.5?
- What are the global sales for CYCLAFEM 0.5?
- What is Average Wholesale Price for CYCLAFEM 0.5?
Summary for CYCLAFEM 0.5
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CYCLAFEM 0.5 at DailyMed |
US Patents and Regulatory Information for CYCLAFEM 0.5
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | CYCLAFEM 0.5/35 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 203413-001 | Dec 16, 2015 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Showing 1 to 1 of 1 entries
